Explore more publications!

Tech News St. Vincent & Grenadines: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.

Press releases published on February 20, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
Purple Appoints Commercial Leader Tom Smith as Regional Growth Director to Lead North East Expansion and Social Impact Strategy
Big Blue Bubble Collaborates with T-Pain to Launch New 'Clubbox' Feature in My Singing Monsters
Gainwell Technologies and Medicaid Leaders to Highlight how States are Navigating H.R. 1 Requirements
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
SEALSQ and Quobly Mutually Agree to Halt Discussions Regarding a Potential Majority Investment or Acquisition by SEALSQ
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
Guardforce AI Announces Share Repurchase Program
Draganfly Welcomes Lieutenant-General (Ret’d) Michel Gauthier to Military Advisory Board in Support of Canada’s Defence Industrial Strategy
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
CT3 Launches On-Chain Commerce Ecosystem and Debuts First OpenSea Integration
Nasus Pharma to Participate in Upcoming Investor Conferences
AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections
Society Pass Incorporated (Nasdaq: SOPA) and NusaTrip Incorporated (Nasdaq: NUTR)  Respond to Nasdaq/SEC Questions Regarding Status of Trading of NUTR’s Securities;  NusaTrip’s Operations Remain Normal and Unaffected by Trading Suspension
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions